A Specific Competitive Antagonist of the Vascular Action of Angiotensin II

Author:

Pals Donald T.1,Masucci Frederick D.1,Sipos Frank1,Denning George S.1

Affiliation:

1. Pharmacology Section and Polypeptide Synthesis Unit, The Norwich Pharmacal Company, Norwich, New York 13815

Abstract

The effect of 1-Asn-8-Ala-angiotensin II (Asn-Arg-Val-Tyr-Val-His-Pro-Ala) on the vascular action of angiotensin II was studied with rabbit aortic strips, pithed rats, and conscious rats. Dose-response (contraction) curves for angiotensin II on rabbit aortic strips shifted progressively to the right with increasing bath concentrations of 1-Asn-8-Ala-angiotensin II. The pA 2 value (an indication of the relative affinity of a competitive antagonist for an agonist's receptor site) was 6.84 ± 0.03. Dose-response curves for norepinephtine, serotonin, and histamine were relatively unaffected. No pA 3 values could be obtained with these agonists in the concentration range tested. Partial dose-response (pressor) curves for angiotensin II in pithed rats shifted to the right during infusions of 1-Asn-8-Ala-angiotensin II at 20 and 60 µg/kg min -1 Partial dose-response curves for vasopressin, phenylephririe, and tyramine were unaffected. Infusions of 1-Asn-8-Ala-angiotensin II counteracted the pressor effect of angiotensin II infusions in pithed and conscious rats. Infusions of 1-Asn-8-Ala-angiotensin II (200 µ/ kg min -1 ) effective in reducing the blood pressure of conscious angiotensin II-infused rats caused only small pressor effects in conscious normotensive rats but reduced the blood pressure in 75% of the conscious rats with acute unilateral renal hypertension. The data presented are consistent with the conclusion that 1-Asn-8-Ala-angiotensin II is a specific competitive antagonist of the vascular action of angiotensin II both in vitro and in vivo.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

Reference17 articles.

1. A Specific Competitive Inhibitor of Angiotensin II

2. Solid Phase Peptide Synthesis. San Francisco;STEWART J.M.;W. H. Freeman & Co.,1969

3. Reactions of strips of rabbit aorta to epinepbrine, isopropylarterenol, sodium nitrite and other drugs;FUHCHGOTT R.F.;J Pharmacol Exp Ther,1953

4. Role of a Pressor Substance in Unilateral Renal Hypertension.

Cited by 200 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Angiotensin II receptors;GPCRs;2020

2. Renin–Angiotensin System;Drug Discovery and Evaluation: Pharmacological Assays;2016

3. Pharmacological and therapeutic properties of new derivatives of renin inhibitors and endothelin receptor antagonists, and the methods of their determination;Analytical Methods;2015

4. Renin–Angiotensin System;Drug Discovery and Evaluation: Pharmacological Assays;2015

5. The Renin-Angiotensin-Aldosterone System in Cardiovascular Diseases;Introduction to Translational Cardiovascular Research;2014-09-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3